1. GBD 2015 Obesity Collaborators. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017;377:13-27.
Article PubMed PMC
2. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013;7:14-24.
Article PubMed PMC PDF
3. Guo M, Ehrlicher AJ, Mahammad S, Fabich H, Jensen MH, Moore JR, et al. The role of vimentin intermediate filaments in cortical and cytoplasmic mechanics. Biophys J 2013;105:1562-1568.
Article PubMed PMC
4. Biskou O, Casanova V, Hooper KM, Kemp S, Wright GP, Satsangi J, et al. The type III intermediate filament vimentin regulates organelle distribution and modulates autophagy. PLoS One 2019;14:e0209665.
Article PubMed PMC
5. Liu CY, Lin HH, Tang MJ, Wang YK. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget 2015;6:15966-15983.
Article PubMed PMC
6. Heid H, Rickelt S, Zimbelmann R, Winter S, Schumacher H, Dorflinger Y, et al. On the formation of lipid droplets in human adipocytes: the organization of the perilipin-vimentin cortex. PLoS One 2014;9:e90386.
Article PubMed PMC
7. Shen WJ, Patel S, Eriksson JE, Kraemer FB. Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis. J Proteome Res 2010;9:1786-1794.
Article PubMed PMC
8. Hirata Y, Hosaka T, Iwata T, Le CT, Jambaldorj B, Teshigawara K, et al. Vimentin binds IRAP and is involved in GLUT4 vesicle trafficking. Biochem Biophys Res Commun 2011;405:96-101.
Article PubMed
9. Wilhelmsson U, Stillemark-Billton P, Boren J, Pekny M. Vimentin is required for normal accumulation of body fat. Biol Chem 2019;400:1157-1162.
Article PubMed PDF
10. Winzell MS, Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53 Suppl 3:S215-S219.
Article PubMed
11. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci 2019;20:E2358.
Article
12. Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med 2014;46:e99.
Article PubMed PMC PDF
13. Govers R. Molecular mechanisms of GLUT4 regulation in adipocytes. Diabetes Metab 2014;40:400-410.
Article PubMed
14. Krintel C, Morgelin M, Logan DT, Holm C. Phosphorylation of hormone-sensitive lipase by protein kinase A in vitro promotes an increase in its hydrophobic surface area. FEBS J 2009;276:4752-4762.
Article PubMed
15. Colucci-Guyon E, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 1994;79:679-694.
Article PubMed
16. Shen WJ, Zaidi SK, Patel S, Cortez Y, Ueno M, Azhar R, et al. Ablation of vimentin results in defective steroidogenesis. Endocrinology 2012;153:3249-3257.
Article PubMed PMC PDF
17. Bjorndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes 2011;2011:490650.
Article PubMed PMC PDF
18. Pepino MY, Love-Gregory L, Klein S, Abumrad NA. The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects. J Lipid Res 2012;53:561-566.
Article PubMed PMC
19. Febbraio M, Silverstein RL. CD36: implications in cardiovascular disease. Int J Biochem Cell Biol 2007;39:2012-2030.
Article PubMed PMC
20. Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cytoadherence of plasmodium falciparum parasitized erythrocytes. Cell 1989;58:95-101.
Article PubMed
21. Griffin E, Re A, Hamel N, Fu C, Bush H, McCaffrey T, et al. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 2001;7:840-846.
Article PubMed PDF
22. Rac ME, Safranow K, Poncyljusz W. Molecular basis of human CD36 gene mutations. Mol Med 2007;13:288-296.
Article PubMed PMC PDF
23. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998;93:229-240.
Article PubMed
24. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999;274:19055-19062.
Article PubMed
25. Abdoul-Azize S, Atek-Mebarki F, Bitam A, Sadou H, Koceir EA, Khan NA. Oro-gustatory perception of dietary lipids and calcium signaling in taste bud cells are altered in nutritionally obesity-prone Psammomys obesus. PLoS One 2013;8:e68532.
Article PubMed PMC
26. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 2002;109:1381-1389.
Article PubMed PMC
27. Furuhashi M, Ura N, Nakata T, Shimamoto K. Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care 2003;26:471-474.
Article PubMed
28. Nath A, Li I, Roberts LR, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep 2015;5:14752.
Article PubMed PMC PDF
29. Chang L, Chiang SH, Saltiel AR. Insulin signaling and the regulation of glucose transport. Mol Med 2004;10:65-71.
Article PubMed PMC PDF
30. Asano T, Fujishiro M, Kushiyama A, Nakatsu Y, Yoneda M, Kamata H, et al. Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions. Biol Pharm Bull 2007;30:1610-1616.
Article PubMed
31. Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab 2007;5:237-252.
Article PubMed
32. Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005;289:E551-E561.
Article PubMed
33. Atkinson BJ, Griesel BA, King CD, Josey MA, Olson AL. Moderate GLUT4 overexpression improves insulin sensitivity and fasting triglyceridemia in high-fat diet-fed transgenic mice. Diabetes 2013;62:2249-2258.
Article PubMed PMC
34. Roefs MM, Carlotti F, Jones K, Wills H, Hamilton A, Verschoor M, et al. Increased vimentin in human α- and β-cells in type 2 diabetes. J Endocrinol 2017;233:217-227.
Article PubMed
35. Kumar N, Robidoux J, Daniel KW, Guzman G, Floering LM, Collins S. Requirement of vimentin filament assembly for beta3-adrenergic receptor activation of ERK MAP kinase and lipolysis. J Biol Chem 2007;282:9244-9250.
Article PubMed
36. Asensio C, Jimenez M, Kuhne F, Rohner-Jeanrenaud F, Muzzin P. The lack of beta-adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and glucose intolerance. Diabetes 2005;54:3490-3495.
Article PubMed
37. Potokar M, Kreft M, Li L, Daniel Andersson J, Pangrsic T, Chowdhury HH, et al. Cytoskeleton and vesicle mobility in astrocytes. Traffic 2007;8:12-20.
Article PubMed
38. Samovski D, Sun J, Pietka T, Gross RW, Eckel RH, Su X, et al. Regulation of AMPK activation by CD36 links fatty acid uptake to β-oxidation. Diabetes 2015;64:353-359.
Article PubMed
39. Zhou D, Samovski D, Okunade AL, Stahl PD, Abumrad NA, Su X. CD36 level and trafficking are determinants of lipolysis in adipocytes. FASEB J 2012;26:4733-4742.
Article PubMed PMC